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Abstract
Adenocarcinoma of the rectum is the most common colorectal cancer in Indonesia. This cancer has the highest 
recurrence after curative surgical therapy with or without adjuvant therapy. With the advancing modern 
histopathology and molecular biology, the prognosis after therapy can be predicted through surveillance 
using tumor cell differentiation and carcinoembryonic antigen (CEA). The aim of this study was to analyze the 
correlation between tumor cell differentiation and serum CEA level in patients with adenocarcinoma of the 
rectum in Dr. Hasan Sadikin General Hospital Bandung, Indonesia. This was a retrospective observational analytic 
study conducted from January 2018–January 2019. There were 36 patients involved in this study consisting of 
3 patients (8.3%) diagnosed with Stage II, 10 patients (27.7%) with Stage IIIA, 20 patients (55.5%) with stage 
IIIB, and 3 patients (8.3%) with stage IIIC. On histopathological examination, it was demonstrated that19 patients 
(52.8%) were well-differentiated, 15 patients (41.7%) were moderately differentiated, and 2 patients (5.6%) 
were poorly differentiated. The mean CEA level (CI 95%) for well-differentiated patients before surgery was 
138.18 (15.99–260.38) ng/mL while the same level for the moderately differentiated patients was 64.34 (34.34–
163.02) ng/mL. The mean CEA level for poorly differentiated patients was 1.55 (6.71–9.81) ng/mL. The result of 
the Kruskal Wallis test showed a p-value of 0.004. There is a strong correlation between the level of tumor cell 
differentiation and CEA level. 
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Hubungan Tingkat Diferensiasi Sel Tumor dengan Kadar Ekspresi CEA 
Pada Pasien Adenokarsinoma Rektum 
Abstrak
Adenokarsinoma rektum merupakan kanker kolorektal paling tinggi di Indonesia. Kanker ini memiliki kekambuhan 
tertinggi setelah terapi bedah kuratif dengan atau tanpa terapi adjuvan. Dengan kemajuan histopatologi dan 
biologi molekuler modern, prognosis setelah terapi dapat diprediksi melalui surveilans menggunakan tingkat 
diferensiasi sel tumor dan carcinoembryonic antigen (CEA). Tujuan penelitian ini adalah menganalisis hubungan 
diferensiasi sel tumor dengan kadar CEA serum pada pasien adenokarsinoma rektum di RSUP Dr. Hasan Sadikin 
Bandung, Indonesia. Penelitian ini merupakan penelitian analitik observasional retrospektif yang dilaksanakan 
pada periode Januari 2018–Januari 2019. Terdapat 36 pasien yang dilibatkan dalam penelitian ini terdiri dari 3 
pasien (8,3%) terdiagnosis Stadium II, 10 pasien (27,7%) Stadium IIIA, 20 pasien (55,5) %) dengan stadium IIIB, 
dan 3 pasien (8,3%) dengan stadium IIIC. Pada pemeriksaan histopatologi, terlihat bahwa 19 pasien (52,8%) 
berdiferensiasi baik, 15 pasien (41,7%) berdiferensiasi sedang, dan 2 pasien (5,6%) berdiferensiasi buruk. Rata-
rata tingkat CEA (CI 95%) untuk pasien dengan diferensiasi baik sebelum operasi adalah 138,18 (15,99–260,38) 
ng/mL sedangkan tingkat yang sama untuk pasien dengan diferensiasi sedang adalah 64,34 (34,34–163,02) 
ng/mL. Rata-rata tingkat CEA untuk pasien dengan diferensiasi buruk adalah 1,55 (6,71–9,81) ng/mL. Hasil uji 
Kruskal Wallis menunjukkan nilai p 0,004. Ada korelasi kuat antara tingkat diferensiasi sel tumor dan tingkat CEA.
Kata kunci: Adenokarsinoma rektum, carcinoembryonic antigen (CEA), tingkat diferensiasi sel tumor
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Introduction
Colorectal cancer is one of the most common 
malignancies in the digestive tract1. Globocan 
in 2018 stated that colorectal cancer is the third 
most common malignant neoplasm worldwide 
and the second global cause of death due to 
cancer.2 In Indonesia, colorectal cancer is the 
fourth most frequent malignancies (12/100.000) 
after breast cancer, cervical cancer, and lung 
cancer. Moreover, rectal cancer is the eighth 
most common cause of death in Indonesia. From 
all various cases of rectal cancer in Indonesia, 
adenocarcinoma is the most common type.3
Patients with adenocarcinoma of the rectum 
at Dr. Hasan Sadikin General Hospital are 
patients with advanced cases, i.e., locoregional 
and with distant metastasis. Patients with 
adenocarcinoma of the rectum have a higher 
recurrence than other colorectal cancer because 
of the nature of the rectum as a narrow pelvic 
cavity. The therapeutic outcome of patients with 
adenocarcinoma of the rectum depends on the 
type, genetics, biology, and level of tumor cell 
differentiation.4
Tumor markers are required to assist 
the diagnosis, and the latest tumor markers 
currently in use have reached the molecular 
level. The recommendation of the American 
Society of Clinical Oncology (ASCO) stated 
that Carcinoembryonic Antigen (CEA) can be 
used as a molecular tumor marker to help the 
staging, planning, and monitoring of therapeutic 
response.5 Tumor cell differentiation is one of the 
factors that influence the CEA level in patients 
with adenocarcinoma of the rectum, with other 
factors include the stage of the tumor, location 
of the tumor, impaired liver function, intestinal 
obstruction, and smoking history. Tumor size is 
also a factor that influences CEA.6,7 
The level of tumor cell differentiation is 
divided into well-differentiated, moderately 
differentiated, poorly differentiated, and 
undifferentiated. Worse tumor cell differentiation 
reflects worse the prognosis.5 
Hence, this study sought to assess the 
correlation between tumor cell differentiation 
and the level of the CEA expression in patients 
with adenocarcinoma of the rectum treated at 
Dr. Hasan Sadikin General Hospital Bandung. In 
terms of benefits, this study is expected to be able 
to assist in the assessment of the prognosis and its 
relevancy to the therapeutic plan in patients with 
adenocarcinoma of the rectum. Furthermore, 
considering most patients come with an 
advanced stage, meaning with a high frequency 
of recurrence, it is necessary to determine the 
best tumor markers in for assessing prognosis 
and postoperative surveillance or definitive 
management.
Methods
This was a cross-sectional retrospective 
analytic observational study on data collected 
from medical records of patients who treated 
at the Digestive Surgery clinic of Dr. Hasan 
Sadikin general Hospital with a diagnosis of 
adenocarcinoma of the rectum from January 
2017–January 2018. This study has been 
approved by Dr. Hasan Sadikin General Hospital’s 
Ethical Committee (LB.02.01/X.6.5/38/2020).  
The inclusion criteria of this study were 
patients diagnosed with adenocarcinoma of the 
rectum based on the results of histopathological 
examination of the adenocarcinoma with 
well-differentiated, moderate differentiated, 
and poorly differentiated degrees with the 
same tumor size and tumor stage that had not 
involved metastasis. The medical record should 
also be complete and included data on gender, 
age, and CEA level, taken immediately after the 
diagnosis was established before surgery or 
other therapies.
The exclusion criteria of this study were 
other malignancies, metastases, presence of 
other chronic diseases (such as impaired liver 
function), synchronous tumors, intestinal 
obstruction, gastroenteritic inflammatory 
diseases as identified from abdominal CT scans 
with contrast, underwent definitive therapy 
(such as surgery and chemotherapy), presence 
of adenocarcinoma of the rectum with other 
histopathological results which did not include 
rectal adenocarcinoma, and smoking history.
Date were then processed and presented in 
the form of narratives, tables, and images based 
on the results of statistical analysis. The One 
Way ANOVA Statistical Test was used when data 
were normally distributed and Kruskal Wallis 
test was used as an alternatives if data were not 
normally distributed. The significance criterion 
used was the p-value with p≤0.05 considered 
to be statistically significant. A p-value of <0.05 
demonstrated a significant correlation between 
the two variables tested while the p-value of > 0.05 
demonstrated otherwise. Data were recorded in 
a dedicated form and then processed using the 
SPSS program version 25.0 for Windows.
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Table 2 CEA Level Before and After Surgery by Tumor Cell Differentiation Level Group
Variable
Level of Tumor Cell Differentiation




CEA Level Before Surgery
Mean (CI 95%) 138.18 (15.99–260.38) 64.34 (34.34–163.02) 1.55 (6.71–9.81)
Median 25.70 7.30 1.55
Range (min–max) 3.80–1000.00 0.20–693.20 0.90–2.20
CEA Level After Surgery
Mean (CI 95%) 89.80 (21.63–201.23) 43.12 (20.93–107.17) 1.25 (8.28–10.78)
Median 19.70 5.40 1.25
Range (min–max) 3.60–1000.00 0.90–447.30 0.50–2.00
*CI : Confident Interval
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Table 1 Subject Characteristics 
Variable (n=36)
Age 
















CEA level before surgery
Mean (CI 95%) 99.83(25.97–173.68)
Median 14.35
Range (min-max) 0.20-1000.00
* CI: confident interval
Results
From January 2017 to January 2018, 36 patients 
with adenocarcinoma of the rectum met the 
inclusion criteria and were recruited as study 
samples. Three patients were diagnosed with 
stage II adenocarcinoma, ten were diagnosed 
with stage IIIA, twenty were diagnosed with 
stage IIIB, and the remaining three were 
diagnosed with stage IIIC.
Data on the Preoperative CEA level was tested 
using the Kruskal Wallis test since the data were 
not distributed normally. The results showed 
that  the preoperative CEA level was 0.004 
(P-value <0.05), which means it was significant 
or statistically significant. Thus, there were 
statistically significant differences between the 
Preoperative CEA Level variables in the Tumor 
Cell Differentiation groups.
Discussion
Carcinoembryonic Antigen (CEA) is widely 
used to assess postoperative recurrence and 
preoperative prognosis. In a study conducted 
by Fahrizal et al., it was stated that there is a 
significant relationship between the CEA level 
and the incidence of metastases in colorectal 
cancer. In their study, it was demonstrated that 
there is a strong and significant relationship 
between the CEA levels and metastatic colorectal 
carcinoma. Of 55 patients with colorectal 
carcinoma, 36 patients have a CEA level  above 
normal limit without metastases and 18 patients 
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Table 3 Comparison between CEA levels before surgery by Tumor Cell Differentiation Group
Variable
Level of Tumor Cell Differentiation




CEA Level Before Surgery 0.004**





Median 25.70 7.30 1.55
Range (min-max) 3.80–1000.00 0.20–693.20 0.90–2.20
*CI : Confident Interval
have metastases in the liver, lungs, and bones.3,4 
Whereas, in a study conducted by Suwanagool 
et al. in Japan, patients with adenocarcinoma of 
the rectum with well-differentiated tumor level 
and the CEA level of  ≥5ng/mL contribute 61.5% 
of the subjects, with the remaining 38.2% and 
0.2% are moderately and poorly differentiated, 
respectively.9 
In this study, the histopathological features are 
divided into 3: well-differentiated, moderately 
differentiated, and poorly differentiated. It 
was found that the most frequently observed 
histopathological features were well-
differentiated (n=19), followed by moderately 
differentiated (n=15) and poorly differentiated 
(n=2). The p-value obtained from the Kruskal 
Wallis statistical analysis was 0.004. This shows 
a significant correlation with positive direction 
and moderate correlation (quite strong) 
between the tumor cell differentiation level and 
the CEA level before therapy. The correlation 
between the level of tumor cell differentiation 
and the CEA level before therapy in patients with 
rectal adenocarcinoma is found to be statistically 
significant (p=0.004). Therefore, it can be 
concluded that there is a relationship between 
the level of tumor cell differentiation and serum 
CEA level before therapy in patients with rectal 
adenocarcinoma at Dr. Hasan Sadikin General 
Hospital Bandung during the period of January 
2017-January 2018. The CEA level before therapy 
in patients with good differentiation will be 
higher compared to those rectal adenocarcinoma 
patients with poor differentiation. Although not 
all rectal adenocarcinoma patients with poor 
differentiation havea  low serum CEA level, in a 
study by Suwanagool et al., for instance, it was 
found that one rectal adenocarcinoma patient 
with poorly differentiation has a high serum CEA 
level, from a total of 55 patients.9
Therefore, for laboratory findings to be 
more efficient and effective, it is recommended 
that CEA examination should be done 
in patients with adenocarcinoma of the 
rectum after the examination of tumor cell 
differentiation, specifically in patients with 
rectal adenocarcinoma with good differentiation. 
Therefore, the laboratory examination costs 
will be more efficient without reducing the 
effectiveness.
This study’s limitation is the small number of 
samples when compared to studies conducted 
by Suwaganool et al. Therefore, further research 
is needed regarding the correlation between 
tumor cell differentiation and serum CEA leves 
before therapy in patients with adenocarcinoma 
of the rectum using larger samples. The two most 
common factors that cause the small number 
of samples of this study include the lack of 
compliance of medical personnel to complete the 
medical records and the lack of awareness of the 
surrounding communities to check their health 
to the doctor. Most of the patients preferred to 
receive traditional treatment rather than medical 
treatment, especially for cancer cases. Therefore, 
many patients came with advanced cases.
In conclusion, patients with good 
differentiation have a higher CEA level. For more 
efficiency and effectiveness, the researchers 
suggest that the CEA level in patients with 
adenocarcinoma of the rectum is examined after 
Tumor Cell Differentiation examination and that 
examination should also be done in patients with 
good differentiation.
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